Comparison  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
Pipelle  ||| S:14 E:22 ||| NNP
sampler  ||| S:22 E:30 ||| NN
with  ||| S:30 E:35 ||| IN
conventional  ||| S:35 E:48 ||| JJ
dilatation  ||| S:48 E:59 ||| NN
and  ||| S:59 E:63 ||| CC
curettage  ||| S:63 E:73 ||| NNS
( ||| S:73 E:74 ||| -LRB-
D ||| S:74 E:75 ||| NNP
& ||| S:75 E:76 ||| CC
C ||| S:76 E:77 ||| NNP
)  ||| S:77 E:79 ||| -RRB-
for  ||| S:79 E:83 ||| IN
Chinese  ||| S:83 E:91 ||| JJ
endometrial  ||| S:91 E:103 ||| NNS
biopsy  ||| S:103 E:110 ||| VBP
The  ||| S:110 E:114 ||| DT
aim  ||| S:114 E:118 ||| NN
of  ||| S:118 E:121 ||| IN
this  ||| S:121 E:126 ||| DT
study  ||| S:126 E:132 ||| NN
is  ||| S:132 E:135 ||| VBZ
to  ||| S:135 E:138 ||| TO
investigate  ||| S:138 E:150 ||| VB
the  ||| S:150 E:154 ||| DT
accuracy  ||| S:154 E:163 ||| NN
and  ||| S:163 E:167 ||| CC
adequacy  ||| S:167 E:176 ||| NN
of  ||| S:176 E:179 ||| IN
the  ||| S:179 E:183 ||| DT
Pipelle  ||| S:183 E:191 ||| JJ
endometrial  ||| S:191 E:203 ||| JJ
sampler  ||| S:203 E:211 ||| NN
for  ||| S:211 E:215 ||| IN
endometrial  ||| S:215 E:227 ||| JJ
biopsy  ||| S:227 E:234 ||| NN
as  ||| S:234 E:237 ||| IN
compared  ||| S:237 E:246 ||| VBN
with  ||| S:246 E:251 ||| IN
those  ||| S:251 E:257 ||| DT
of  ||| S:257 E:260 ||| IN
conventional  ||| S:260 E:273 ||| JJ
dilatation  ||| S:273 E:284 ||| NN
and  ||| S:284 E:288 ||| CC
curettage  ||| S:288 E:298 ||| NNS
( ||| S:298 E:299 ||| -LRB-
D ||| S:299 E:300 ||| NNP
& ||| S:300 E:301 ||| CC
C ||| S:301 E:302 ||| NNP
) ||| S:302 E:303 ||| -RRB-
.  ||| S:303 E:305 ||| .
A  ||| S:305 E:307 ||| DT
total  ||| S:307 E:313 ||| NN
of  ||| S:313 E:316 ||| IN
245  ||| S:316 E:320 ||| CD
patients  ||| S:320 E:329 ||| NNS
subject  ||| S:329 E:337 ||| JJ
to  ||| S:337 E:340 ||| TO
endometrial  ||| S:340 E:352 ||| VB
biopsy  ||| S:352 E:359 ||| NNS
were  ||| S:359 E:364 ||| VBD
included  ||| S:364 E:373 ||| VBN
in  ||| S:373 E:376 ||| IN
this  ||| S:376 E:381 ||| DT
study ||| S:381 E:386 ||| NN
.  ||| S:386 E:388 ||| .
We  ||| S:388 E:391 ||| PRP
have  ||| S:391 E:396 ||| VBP
shown  ||| S:396 E:402 ||| VBN
that  ||| S:402 E:407 ||| IN
the  ||| S:407 E:411 ||| DT
failure  ||| S:411 E:419 ||| NN
rates  ||| S:419 E:425 ||| NNS
with  ||| S:425 E:430 ||| IN
D ||| S:430 E:431 ||| NNP
& ||| S:431 E:432 ||| CC
C  ||| S:432 E:434 ||| NNP
and  ||| S:434 E:438 ||| CC
Pipelle  ||| S:438 E:446 ||| NNP
were  ||| S:446 E:451 ||| VBD
7.75 ||| S:451 E:455 ||| CD
%  ||| S:455 E:457 ||| NN
and  ||| S:457 E:461 ||| CC
8.98 ||| S:461 E:465 ||| CD
% ||| S:465 E:466 ||| NN
,  ||| S:466 E:468 ||| ,
respectively ||| S:468 E:480 ||| RB
,  ||| S:480 E:482 ||| ,
without  ||| S:482 E:490 ||| IN
statistical  ||| S:490 E:502 ||| JJ
difference ||| S:502 E:512 ||| NN
.  ||| S:512 E:514 ||| .
Additionally ||| S:514 E:526 ||| RB
,  ||| S:526 E:528 ||| ,
the  ||| S:528 E:532 ||| DT
obtained  ||| S:532 E:541 ||| VBN
specimen  ||| S:541 E:550 ||| JJ
quality  ||| S:550 E:558 ||| NN
and  ||| S:558 E:562 ||| CC
accurate  ||| S:562 E:571 ||| JJ
diagnosis  ||| S:571 E:581 ||| NN
of  ||| S:581 E:584 ||| IN
various  ||| S:584 E:592 ||| JJ
diseases  ||| S:592 E:601 ||| NNS
using  ||| S:601 E:607 ||| VBG
the  ||| S:607 E:611 ||| DT
two  ||| S:611 E:615 ||| CD
methods  ||| S:615 E:623 ||| NNS
had  ||| S:623 E:627 ||| VBD
no  ||| S:627 E:630 ||| DT
significant  ||| S:630 E:642 ||| JJ
statistical  ||| S:642 E:654 ||| JJ
differences ||| S:654 E:665 ||| NNS
.  ||| S:665 E:667 ||| .
Furthermore ||| S:667 E:678 ||| RB
,  ||| S:678 E:680 ||| ,
patients  ||| S:680 E:689 ||| NNS
experienced  ||| S:689 E:701 ||| VBD
less  ||| S:701 E:706 ||| JJR
pain  ||| S:706 E:711 ||| NN
when  ||| S:711 E:716 ||| WRB
Pipelle  ||| S:716 E:724 ||| NNP
sampler  ||| S:724 E:732 ||| NN
was  ||| S:732 E:736 ||| VBD
used  ||| S:736 E:741 ||| VBN
than  ||| S:741 E:746 ||| IN
D ||| S:746 E:747 ||| NNP
& ||| S:747 E:748 ||| CC
C ||| S:748 E:749 ||| NNP
.  ||| S:749 E:751 ||| .
Therefore ||| S:751 E:760 ||| RB
,  ||| S:760 E:762 ||| ,
Pipelle  ||| S:762 E:770 ||| NNP
sampler  ||| S:770 E:778 ||| NN
is  ||| S:778 E:781 ||| VBZ
effective  ||| S:781 E:791 ||| JJ
in  ||| S:791 E:794 ||| IN
obtaining  ||| S:794 E:804 ||| VBG
adequate  ||| S:804 E:813 ||| JJ
endometrial  ||| S:813 E:825 ||| JJ
tissue  ||| S:825 E:832 ||| NN
for  ||| S:832 E:836 ||| IN
histodiagnosis ||| S:836 E:850 ||| NN
,  ||| S:850 E:852 ||| ,
and  ||| S:852 E:856 ||| CC
is  ||| S:856 E:859 ||| VBZ
applicable  ||| S:859 E:870 ||| JJ
in  ||| S:870 E:873 ||| IN
most  ||| S:873 E:878 ||| JJS
of  ||| S:878 E:881 ||| IN
the  ||| S:881 E:885 ||| DT
cases  ||| S:885 E:891 ||| NNS
for  ||| S:891 E:895 ||| IN
Chinese  ||| S:895 E:903 ||| JJ
endometrial  ||| S:903 E:915 ||| JJ
biopsy ||| S:915 E:921 ||| NN
.  ||| S:921 E:923 ||| .
